MS4A1 and B-cell chronic lymphocytic leukemia: Flow cytometric immunophenotyping studies (Table 2) showed that all groups expressed CD19 and CD20 without statistically significant changes (p = 0.1 and p = 0.2, respectively), but in the case of CD22, all the patients, except B-CLL cases, expressed this marker (p = 0.000).